/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749804846&Signature=c0NX1UB00K7iNMPh507IOwvamf2Dy7RTB5e5lRtZX-kPNInfLVqKoSHVLH-XfEkPPgRYbqpn5tLjoKXS5boqcu~9mK59iuSz9BS4HahtERLzAHWs0RnY5gWbgYb26gCnZ~X47clG2iELB6mTH88t0Ej0MtiI~QYOtYI-YaTFSE8eUvo8aDo7S4ZWX~M~53O3GCoRmmL1yBl17YFcbS4BD9Yby6i7xsfqg1CLIr7cYlSUMHiz4glVH~1~WbEvQ1uRixzvACucEBroX8wFSYBKpeXqU2mDaFnc1FxO1xSxFKx-wMjiKQUYKSjkuVR5Dkh8LsUcNAx2CO7khhdADBabsA__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
European Medical Solutions | Belgium | ALEMS | |
|
Evogene Ltd. | Israel | EVGN | |
|
Evolva Holding SA | Switzerland | EVE | |
|
EXACT Therapeutics AS | Norway | EXTX | |
|
Exosens | France | EXENS | |
|
ExpreS2ion Biotech Holding AB | Sweden | EXPRS2 | |
|
Fermentalg | France | ALGAE | |
|
Formycon AG | Germany | FYB | |
|
FRONTIER IP GROUP PLC | United Kingdom | FIPP | |
|
Gabather AB | Sweden | GABA |